Urinary antigen testing for pneumococcal pneumonia: is there evidence to make its use uncommon in clinical practice? Source: ERJ Open Res, 6 (1) 00223-2019; 10.1183/23120541.00223-2019 Year: 2020
Do physicians use urinary pneumococcal antigen test (UPAT) appropriately? Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012
Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011
Usefulness of urinary pneumococcal antigen testing in patients with community acquired pneumonia Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009
The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals Source: ERJ Open Res, 2 (4) 00011-2016; 10.1183/23120541.00011-2016 Year: 2016
The influence of modern microbiological methods on the antibiotic treatment of pneumonia in children Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018
IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012
Impact of determination of urine pneumococcal antigen in the diagnosis of community acquired pneumonia Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008
Applying sputum as a diagnostic tool in pneumonia - limited yield, minimal impact on treatment decisions Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy Source: Breathe, 15 (4) 296; 10.1183/20734735.0258-2019 Year: 2019
The relationship between the result of urinary antigen detection kit for Streptococcus pneumoniae and clinical effect of treatment in patients with pneumococcal pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004
Usefulness of mannitol challenge testing for diagnosing asthma in everyday clinical practice Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018
Changes in empirical initial antibiotic therapy in community-acquired pneumonia: assessment of clinical failure versus discordant therapy Source: Eur Respir J 2006; 28: Suppl. 50, 736s Year: 2006
Use of streptococcus antigen's express-diagnostic test for rational antibiotic therapy in patients with pharyngitis Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002
Investigation of factors associated with result of pneumococcal urinary antigen in the microbiological investigation of pneumococcal lower respiratory infections Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017
The role of inhaled antibiotics in bronchial infection Source: Eur Respir Monogr 2013; 60: 120-126 Year: 2013
The clinical and bacteriological basis for initiating a specific treatment Source: Annual Congress 2006 - PG11 - Clinical highlights on tuberculosis Year: 2006
A clinical and aetiological evaluation of community acquired pneumonia-are we following guidelines in prescribing antibiotics? Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
The efficacy of antiviral therapy of acute respiratory infections in paediatric practice Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017